Sara Jane Ward, PhD
Adjunct Instructor
Contact
Sara Jane Ward, PhD
Adjunct Instructor
Education
PhD, Neuroscience, Wake Forest University School of Medicine, Winston-Salem, NC - 2004
BA, Psychology, University of Connecticut, Storrs, CT - 1997
Publications
- Kratom alkaloid mitragynine: Inhibition of chemotherapy-induced peripheral neuropathy in mice is dependent on sex and active adrenergic and opioid receptors
- Anti-Inflammatory Properties of KLS-13019: a Novel GPR55 Antagonist for Dorsal Root Ganglion and Hippocampal Cultures
- Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966
- Cannabinoids and Cancer Chemotherapy-Associated Adverse Effects
- Behavioural and pharmacological effects of cannabidiol (CBD) and the cannabidiol analogue KLS-13019 in mouse models of pain and reinforcement
Research & Interest
Behavioral pharmacological effects of the cannabinoid, serotonin, & opioid receptor systems on neuropathic pain & neuroprotection, learning & memory, & addiction.
Biography
Dr. Sara Jane Ward is an Assistant Professor in the Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University.
She earned her PhD in neuroscience at Wake Forest University in Winston-Salem NC. Dr. Ward is currently working on several projects to elucidate the therapeutic potential of non-psychoactive cannabinoids, including studies supported by the National Institutes of Health and Department of Defense investigating the efficacy of cannabidiol for the treatment of peripheral and central neuropathic pain. Other projects include investigating the efficacy of cannabidiol and synthetic cannabinoids on a range of nervous system targets including stroke, traumatic brain injury, and addiction.
Teaching
Health Implications of Medicinal Cannabi
Conventional & Cannabinoid Therapy of Disease
Pathology Potentially Responsive to Cannabis